Strategies for obtaining bone biopsy specimens from breast cancer patients - Past experience and future directions. - Wikidata - wikimedia - TriplyDB

Strategies for obtaining bone biopsy specimens from breast cancer patients - Past experience and future directions.

Strategies for obtaining bone biopsy specimens from breast cancer patients - Past experience and future directions.

http://www.wikidata.org/entity/Q37500001

about

Strategies for obtaining bone biopsy specimens from breast cancer patients - Past experience and future directions.

http://www.wikidata.org/entity/Q37500001

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 07 July 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Strategies for obtaining bone ...... erience and future directions.

@en

Strategies for obtaining bone ...... erience and future directions.

@nl

type

label

Strategies for obtaining bone ...... erience and future directions.

@en

Strategies for obtaining bone ...... erience and future directions.

@nl

prefLabel

Strategies for obtaining bone ...... erience and future directions.

@en

Strategies for obtaining bone ...... erience and future directions.

@nl

P1433

Q37500001-36BC45FA-20BF-4195-9879-EF82BD6A1CA4

P1476

Q37500001-1584FE3D-A125-4C6E-ACA1-A7E0C9C48BC7

P2093

Q37500001-186CDE3A-69DC-457F-920E-F5B8FED0ED10

Q37500001-19E26187-4F91-4BDC-8172-FAFADC7251AB

Q37500001-543E1AF6-DBC0-4018-80E5-21F68934DB94

Q37500001-6872725E-740A-46B8-9BFD-CCA4D274BCF8

Q37500001-7216DC62-E8E4-4944-9365-99615488CA5A

Q37500001-8372CBC2-2139-4BB3-B7BF-57937546D6C9

Q37500001-A56DAF6D-1F1C-435B-9117-FA4D704F91A8

Q37500001-FE28B389-3270-4361-BC16-C23D57CB05EA

P2860

Q37500001-11FC4960-B0EA-40D1-A169-FA497278313A

Q37500001-1F3D7A44-8168-4951-945A-ABC019183115

Q37500001-208EE76B-FA2C-4FE3-9A48-EBE134610259

Q37500001-2C5A348B-5012-48C8-B4CD-AA71A24EE0A5

Q37500001-385542BB-DAF6-4AAD-9163-C6DA43D1D306

Q37500001-3CFD7B96-1B3B-444F-9D3D-878E6D6E2AD4

Q37500001-55F6334A-C385-41AB-A045-72D4E6F0FB6B

Q37500001-6019AE19-2F2E-41AD-A5E5-61F25277C941

Q37500001-6CBF670F-0B6A-4269-BA3A-BD50497EA745

Q37500001-75914497-50BE-4AA1-A916-8AFC32A90B41

P304

Q37500001-DC4D3EFF-8911-4E1A-A7EF-2F2EF6232A2A

P31

Q37500001-1854509A-08B2-458C-9A2B-E5EE07B4CA1C

P356

Q37500001-41D755F6-5A8D-42B7-8629-52B54A5B5E63

P433

Q37500001-920A31A3-3DB3-4BDA-A3DA-B85E61152ED5

P478

Q37500001-E6AD82E3-54C3-495A-B56C-60CD652CDC1E

P50

Q37500001-358B91CC-BBE4-4FC6-B68D-9D0D66DE39A6

P577

Q37500001-4839CFD1-7B04-4449-A053-681DAFD04785

P698

Q37500001-89638CCF-2B17-49B2-A402-CB0E874DA7B3

P921

Q37500001-8417C898-A786-4390-9653-94081EF2006F

P932

Q37500001-8A1EB0B5-2BB0-4D9E-95A3-964BAB433B24

P356

J.JBO.2016.07.001

P1433

Journal of bone oncology

P1476

Strategies for obtaining bone ...... erience and future directions.

@en

P2093

Carmel Jacobs

http://www.w3.org/2001/XMLSchema#string

Christina Addison

http://www.w3.org/2001/XMLSchema#string

Joel Werier

http://www.w3.org/2001/XMLSchema#string

John Hilton

http://www.w3.org/2001/XMLSchema#string

Lisa Vandermeer

http://www.w3.org/2001/XMLSchema#string

Mark Clemons

http://www.w3.org/2001/XMLSchema#string

Mohammed F K Ibrahim

http://www.w3.org/2001/XMLSchema#string

Susan Robertson

http://www.w3.org/2001/XMLSchema#string

P2860

CCN3 impairs osteoblast and stimulates osteoclast differentiation to favor breast cancer metastasis to bone

Metastasis to bone: causes, consequences and therapeutic opportunities

Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials.

Zoledronic acid has differential antitumor activity in the pre- and postmenopausal bone microenvironment in vivo

Cancer micrometastases.

Controversies in clinical cancer dormancy

Loss of human epidermal growth factor receptor 2 (HER2) expression in metastatic sites of HER2-overexpressing primary breast tumors.

Correlation of baseline biomarkers with clinical outcomes and response to fulvestrant with vandetanib or placebo in patients with bone predominant metastatic breast cancer: An OCOG ZAMBONEY sub-study

Adjuvant bisphosphonate treatment for breast cancer: Where are we heading and can the pre-clinical literature help us get there?

Histomorphometric and microarchitectural analyses using the 2 mm bone marrow trephine in metastatic breast cancer patients-preliminary results

P304

180-184

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JBO.2016.07.001

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Sasha Mazzarello

P577

2016-07-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28008380

http://www.w3.org/2001/XMLSchema#string

P921

P932

5154702

http://www.w3.org/2001/XMLSchema#string